Click here to read or make comments on this topic »
AllAfrica aggregates and indexes content from over 125 African news organizations, plus more than 200 other sources, who are responsible for their own reporting and views. Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica.
About 500 people have the difficulty to treat tuberculosis strain called Multiple Drug Resistant (MDR) TB, majority of whom are not in any kind of treatment programme.
The Eastern Cape Health Department has dispatched officials to round up 18 tuberculosis (TB) patients, who urgently need to continue with their treatment in hospital.
Participants at a one day Tuberculosis (TB) control and prevention workshop in Tubmanburg, Bomi County have pledged their support for the prevention of the disease in Liberia.
Identifying individuals with chronic cough lasting over two weeks to test them for tuberculosis (Active Case Finding) could supplement the current strategy where suspects voluntarily avail themselves to health facilities (Passive Case Finding) for diagnosis.
Towards Mitigating the Burden of Multi-drug-resistant tuberculosis (MDR-TB) in Nigeria, the Federal government in collaboration with the Global TB Partnership and USAID, is conducting a prevalence survey of persons with TB that is resistant to treatment with first-line anti-TB drugs in the country.
The first new tuberculosis drug in 40 years has successfully treated multidrug-resistant tuberculosis (MDR-TB) patients in a clinical trial in South Africa.
Pharmaceutical giant Tibotec and the non-profit Global Alliance for TB Drug Development (TB Alliance) have teamed up to expedite the development of TMC207, which could become the first TB drug with a new mechanism of action in 40 years.
Active Discussions: Tuberculosis